Free online seminar Thursday 19th August, 2021 1-2pm AEST. 

This seminar will be co-presented by Prof. Rebecca Ritchie and Dr. Darnel Prakoso

 Prof. Rebecca Ritchie

Glucose-driven protein modifications critically regulate diabetic heart phenotype

Rebecca Ritchie is the head of Drug Discovery Biology in the Monash Institute of Pharmaceutical Sciences (MIPS) in Parkville, in addition to leading the Heart Failure Pharmacology laboratory within DDB. She also serves as Co Director (with Prof Grant Drummond) of the ACvA Drug Discovery and Translation Flagship. Rebecca’s research objective is the identification of new treatment strategies for arresting the progression of heart failure, particularly in the context of diabetes, myocardial infarction and other inflammatory disorders.

 Dr. Darnel Prakoso

Targeting impaired glucose metabolism as a treatment for diabetic cardiomyopathy

Dr Prakoso is an early career researcher in the Heart Failure Pharmacology lab in Drug Discovery Biology at MIPS. Darnel received his PhD from the University of Melbourne in 2019 and continued his work with Dr De Blasio and Prof Ritchie to investigate novel genetic therapies for the treatment of diabetes induced heart failure. Within one year of completing his PhD, he has 13 publications in high impact factor journals including Cardiovascular Research, Scientific Reports, Clinical Science and Am J Physiol. He recently acquired both the Diabetes Australia and Heart Foundation Project Grant to further investigate the sexual dimorphism of the diabetic heart.

August 13 2021